Mesothelin, a novel immunotherapy target for triple negative breast cancer

Mesothelin is a cell-surface glycoprotein present on mesothelial cells and elicits T-cell responses in a variety of cancers including pancreatic and ovarian cancer. Breast cancer is not known to express mesothelin. We postulated that mesothelin may be a unique tumor associated antigen in triple nega...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Breast Cancer Res Treat
Asıl Yazarlar: Tchou, Julia, Wang, Liang-Chuan, Selven, Ben, Zhang, Hongtao, Conejo-Garcia, Jose, Borghaei, Hossein, Vondeheide, Robert H, Albelda, Steven M., June, Carl H, Zhang, Paul J
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4964602/
https://ncbi.nlm.nih.gov/pubmed/22418702
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-012-2018-4
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller